VUTURO, Onofrio
 Distribuzione geografica
Continente #
NA - Nord America 578
EU - Europa 271
AS - Asia 103
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 955
Nazione #
US - Stati Uniti d'America 578
UA - Ucraina 67
FI - Finlandia 66
CN - Cina 62
IT - Italia 48
SG - Singapore 26
IE - Irlanda 23
GB - Regno Unito 16
SE - Svezia 15
DE - Germania 13
BE - Belgio 7
RU - Federazione Russa 6
KR - Corea 5
FR - Francia 4
IR - Iran 3
TR - Turchia 3
CI - Costa d'Avorio 2
IN - India 2
RO - Romania 2
AT - Austria 1
CZ - Repubblica Ceca 1
EU - Europa 1
HK - Hong Kong 1
NL - Olanda 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 955
Città #
Chandler 74
Fairfield 61
Ashburn 51
Wilmington 38
Ann Arbor 37
Jacksonville 36
Houston 35
Des Moines 28
Dublin 23
Seattle 23
Woodbridge 22
New York 19
Cambridge 18
Singapore 18
Medford 15
Nanjing 13
Princeton 11
Boardman 10
Tulsa 9
Brussels 7
Dearborn 7
Nanchang 6
Palermo 6
Shenyang 6
Altamura 5
Lawrence 5
Seongnam 5
Hebei 4
Ningbo 4
San Diego 4
Beijing 3
Changsha 3
Haikou 3
Hangzhou 3
Izmir 3
Tehran 3
Tianjin 3
Abidjan 2
Chicago 2
Duncan 2
Guangzhou 2
Jinan 2
Kiev 2
Kunming 2
Lanzhou 2
Milan 2
Castagnole delle Lanze 1
Central District 1
Columbus 1
Den Haag 1
Hefei 1
Helsinki 1
Islington 1
Jiaxing 1
Kilburn 1
Kumar 1
Ludwigshafen am Rhein 1
Munich 1
Olomouc 1
Orange 1
Redmond 1
Saint Petersburg 1
Salerno 1
San Mateo 1
Santa Clara 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Venice 1
Verona 1
Zhengzhou 1
Totale 664
Nome #
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 153
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 125
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 125
Retreatment of interferon plus ribavirin unresponsive patients with chronic hepatitis C with peginterferon alfa 2a plus mycofenolatemofetile or peginterferon alfa 2 a plus ribavirin 91
Affidabilità del Bright liver echopattern nella diagnosi di steatosi in pazienti con ipertransaminasemia criptogenetica 90
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 85
Safety and efficacy of peginterferon alpha 2a plus mycofenolatemofetile and peginterferon alpha 2a plus Ribavirin in unresponsive patients with chronic hepatitis C 72
safety and efficacy of peginterferon (PEG-IFN) alpha 2a plus mycofenolatemoftile and peginterfron alpha 2a plus ribavirin in unresponsive patients with chronic C hepatitis 67
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC). 57
Viral clearance in HCV viraemic patients with normal aminotransferase after combination therapy: a controlled, open-labelled study 56
Randomised trial of two different daily doses of interferon-α versus classical therapy in treatment-naïve patients with chronic hepatitis C 55
Totale 976
Categoria #
all - tutte 3.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020135 0 0 0 0 0 28 29 10 24 8 23 13
2020/2021116 1 14 6 13 11 6 10 6 15 6 11 17
2021/2022105 3 28 1 9 3 2 5 4 10 13 7 20
2022/2023172 14 28 1 21 24 31 22 13 9 1 6 2
2023/202491 5 9 3 25 4 20 2 2 0 0 8 13
2024/202532 5 6 2 6 3 10 0 0 0 0 0 0
Totale 976